Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 46

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 46
---

stock, along with any limitations or restrictions, including voting rights, dividend rights, conversion rights, redemption privileges
and liquidation preferences of each class or series of preferred stock.

Each series of preferred stock,
if issued, will be more fully described in the particular prospectus supplement that will accompany this prospectus, including redemption
provisions, rights in the event of our liquidation, dissolution or winding-up, voting rights and rights to convert into common stock.

Warrants.

We may issue warrants for
the purchase of common stock or preferred stock, in one or more series, from time to time. We may issue warrants independently or together
with common stock, preferred stock or debt securities, and the warrants may be attached to or separate from our common stock, preferred
stock or debt securities. In this prospectus, we have summarized certain general features of the warrants. We urge you, however, to read
the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the particular
series of warrants being offered, as well as the complete warrant agreement and warrant certificate that contain the terms of the warrants.
We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports
that we file with the SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular
series of warrants we are offering before the issuance of the related series of warrants.

<div align='center'>9</div>

We will evidence each series
of warrants by warrant certificates that we will issue. Warrants may be issued under an applicable warrant agreement that we enter into
with a warrant agent. We will indicate the name and address of the warrant agent, if applicable, in the prospectus supplement relating
to the particular series of warrants being offered.

Debt Securities.

We may offer secured or unsecured
obligations in the form of one or more series of debt securities, which may be senior, senior subordinated or subordinated obligations.
Any subordinated debt securities generally will be entitled to payment only after payment of our senior debt. Senior debt generally includes
all debt for money borrowed by us, except debt that is stated in the instrument governing the terms of that debt to be not senior to,
or to have the same rank in right of payment as, or to be expressly junior to, the subordinated debt securities. We may issue debt securities
that are convertible into shares of